1.Challenges and countermeasures of ethics in medical research in the digital intelligence era
Yu ZHANG ; Zhengkun CUI ; Yahong CHEN
Chinese Journal of Medical Science Research Management 2025;38(4):275-283
Objective:To explore and discuss the ethical issues and challenges arising from the rapid development of digital intelligence technology in medical research, and to propose strategies for addressing them.Methods:By reviewing the applications of big data, artificial intelligence, and other technologies in medical research, as well as the related ethical issues, discussions and analyses were conducted on aspects such as informed consent, privacy protection, data security, and algorithmic bias.Results:To address the numerous ethics issues and challenges in medical research in the digital intelligence era, researchers and institutions should actively respond with a stance of inclusivity and prudence.Conclusions:By improving the informed consent process, strengthening legal and policy frameworks, promoting interdisciplinary collaboration, and establishing risk assessment mechanisms, we can promote the continuous innovation and high-quality development of medical knowledge and practice.
2.Transient Peripheral Carotid Inflammation Syndrome Diagnosed by Contrast-enhanced Ultrasound:A Case Report
Chunlei PAN ; Ying WANG ; Yahong WANG ; Li ZHANG ; Zhitong GE ; Yu CHEN ; Sheng CAI ; Hongyan WANG ; Xiao YANG ; Jianchu LI
Medical Journal of Peking Union Medical College Hospital 2025;16(3):785-789
Transient perivascular inflammation of the carotid artery(TIPIC)syndrome is a relatively rare disease,and ultrasound is the first screening method for initial diagnosis of the disease.Contrast-enhanced ultrasound(CEUS)has unique advantages in the follow-up of patients with TIPIC syndrome.This paper reports a patient with TIPIC syndrome who was treated with acute left neck pain.The inflammation was significantly re-lieved and subsided after treatment with non-steroidal anti-inflammatory drugs.The ultrasound changes of carotid artery lesions in this patient during follow-up were analyzed,and the application value of CEUS in the follow-up diagnosis of this disease was summarized,in the hope of providing clinical reference.
3.Challenges and countermeasures of ethics in medical research in the digital intelligence era
Yu ZHANG ; Zhengkun CUI ; Yahong CHEN
Chinese Journal of Medical Science Research Management 2025;38(4):275-283
Objective:To explore and discuss the ethical issues and challenges arising from the rapid development of digital intelligence technology in medical research, and to propose strategies for addressing them.Methods:By reviewing the applications of big data, artificial intelligence, and other technologies in medical research, as well as the related ethical issues, discussions and analyses were conducted on aspects such as informed consent, privacy protection, data security, and algorithmic bias.Results:To address the numerous ethics issues and challenges in medical research in the digital intelligence era, researchers and institutions should actively respond with a stance of inclusivity and prudence.Conclusions:By improving the informed consent process, strengthening legal and policy frameworks, promoting interdisciplinary collaboration, and establishing risk assessment mechanisms, we can promote the continuous innovation and high-quality development of medical knowledge and practice.
4.Exploration and reflections on applying the 6W2H analysis method to construct a broad consent management system in healthcare institutions
Yu ZHANG ; Haiyan LI ; Yahong CHEN
Chinese Journal of Medical Science Research Management 2024;37(3):173-180
Objective:This study aimed to explore the management system and procedures for broad consent in healthcare institutions for the effective and efficient implementation of broad consent, to protect the rights and interests of research participants, and to improve research efficiency.Methods:Using the 6W2H analysis method, key decision points such as background, goal orientation, operating mode, time node, applicable scope, key roles, procedure operation, and operating costs were explored and analyzed.Results:Broad consent should be implemented to protect the rights and interests of research participants as the primary core goal, and collaborate with multiple departments to establish a matching management system.Conclusions:The implementation of broad consent still faces many challenges. It is necessary to improve the scientific ethics governance system, increase the popularization of science to win public support, and strengthen the supervision of personal information protection.
5.Transient Peripheral Carotid Inflammation Syndrome Diagnosed by Contrast-enhanced Ultrasound: A Case Report
Chunlei PAN ; Ying WANG ; Yahong WANG ; Li ZHANG ; Zhitong GE ; Yu CHEN ; Sheng CAI ; Hongyan WANG ; Xiao YANG ; Jianchu LI
Medical Journal of Peking Union Medical College Hospital 2024;16(3):785-789
Transient perivascular inflammation of the carotid artery (TIPIC) syndrome is a relatively rare disease, and ultrasound is the first screening method for initial diagnosis of the disease. Contrast-enhanced ultrasound (CEUS) has unique advantages in the follow-up of patients with TIPIC syndrome. This paper reports a patient with TIPIC syndrome who was treated with acute left neck pain. The inflammation was significantly relieved and subsided after treatment with non-steroidal anti-inflammatory drugs. The ultrasound changes of carotid artery lesions in this patient during follow-up were analyzed, and the application value of CEUS in the follow-up diagnosis of this disease was summarized, in the hope of providing clinical reference.
6.Epidural Labor Analgesia: Comfort and Safety Run in Parallel, with Teaching and Quality Control Complementing Each Other
Yu ZHANG ; Mengyun ZHAO ; Lijian PEI ; Yahong GONG ; Xia RUAN ; Yuguan ZHANG ; Di XIA ; Zhilong LU ; Zhanjie ZHANG ; Jiong ZHOU ; Chenwei FU ; Jinsong GAO ; Yuguang HUANG
Medical Journal of Peking Union Medical College Hospital 2024;15(2):246-250
Epidural labor analgesia aims to provide effective medical services to alleviate labor pain in parturients, while adhering to the principles of voluntary participation and clinical safety. In 2018, Peking Union Medical College Hospital(PUMCH)became one of the first pilot units for labor analgesia in China, and has achieved satisfactory results in high-quality development of labor analgesia. This article mainly introduces the achievements and experience of labor analgesia at PUMCH, including: (1) prioritizing maternal and infant safety, arranging personnel rationally, and developing standardized treatment processes through multidisciplinary collaboration to ensure safe and comfortable childbirth; (2) leveraging the hospital's comprehensive capabilities in emergency treatment, and improving collaborative rescue plans for critically ill parturients and newborns; (3) implementing advanced teaching methods to effectively train and conduct simulated drills for labor analgesia and rescue of critically ill parturients; (4) conducting patient education and informative lectures to help parturients acquire a scientific understanding of labor analgesia. We hope that this experience can provide reference and inspiration for other hospitals.
7.Exploring Mechanism of Different Processed Products of Baiyaojian and Its Formula in Treating Ulcerative Colitis Based on Serum Metabolomics and Flow Cytometry
Ruisheng WANG ; Yafang HOU ; Wenwen CAO ; Yahong ZHAO ; Zhenling ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(15):172-181
ObjectiveTo explore the potential mechanism of different processed products of Baiyaojian and its compound Xiangmei pills in rats with ulcerative colitis(UC) by comparing the pharmacodynamic and metabolomic differences. MethodEighty SD rats were acclimatized and kept for 3 d, and randomly divided into 8 groups[blank group, model group, mesalazine group(0.4 g·kg-1), Baiyaojian group(1.89 g·kg-1), stir-fried Baiyaojian group(1.89 g·kg-1), carbonized Baiyaojian group(1.89 g·kg-1), and Xiangmei pills low and high dose groups(1.89, 5.67 g·kg-1)], with 10 rats in each group. Rats in the blank group were administered physiological saline by gavage, and rats in the remaining 7 groups were orally administered 5% dextran sodium sulfate(DSS) solution daily for 8 consecutive days to induce UC model. After successful modeling, each dosing group was given the corresponding dose of drug solution by gavage, and the blank and model groups were given equal amounts of saline by gavage, and the drug was administered continuously for 8 d. Then serum levels of tumor necrosis factor-α(TNF-α), interleukin(IL)-6, IL-10 and IL-1β were measured by enzyme-linked immunosorbent assay(ELISA), hematoxylin-eosin(HE) staining was used to observe the histopathological changes of colon tissue, the proportion of T helper 17 cells(Th17) and regulatory T cells(Treg) in the peripheral blood of rats in each group was detected by flow cytometry. The endogenous metabolites in serum of rats were detected by ultra performance liquid chromatography-quadrupole/electrostatic field orbitrap high-resolution mass spectrometry(UPLC-Q-Exactive Orbitrap MS), and the differential metabolites were characterized by combining principal component analysis(PCA) and orthogonal partial least squares-discriminant analysis(OPLS-DA), and were analyzed according to the variable importance in the projection(VIP) value>1.0 and P<0.05, and potential metabolic pathways were analyzed according to Human Metabolome Database(HMDB). ResultCompared with the blank group, the colon tissue of the model group was congested and the mucosa was ulcerated, the colon length was significantly reduced(P<0.01) and the quality was significantly increased(P<0.05), the proportion of Th17/Treg in the peripheral blood and the serum levels of TNF-α, IL-6 and IL-1β were significantly increased, while the IL-10 expression wassignificantly reduced(P<0.05, P<0.01). Compared with the model group, the colon tissue of UC rats in each treatment group was improved with scattered ulcers, reduced inflammatory cell infiltration, significantly increased colon length, and significantly decreased mass(P<0.05), the proportion of Th17/Treg in the peripheral blood decreased, the expression of TNF-α,IL-6 and IL-1β was significantly reduced(P<0.05, P<0.01), while the IL-10 expression was significantly increased(P<0.01). The therapeutic effect of different administration groups on UC was in the order of high dose group of Xiangmei pills>low dose group of Xiangmei pills>carbonized Baiyaojian group>stir-fried Baiyaojian group>Baiyaojian group. And a total of 26 differential metabolites were screened in the metabolomics results. Compared with the blank group, 14 differential metabolites were up-regulated and 5 metabolites were down-regulated in the model group, and 14, 9, 14, 12 and 17 metabolites could be recalled in the Baiyaojian group, stir-fried Baiyaojian group, carbonized Baiyaojian group, Xiangmei pills low and high dose groups. The main metabolic pathways involved were citrate cycle pathway, pantothenic acid and coenzyme A biosynthesis pathway, aromatic hydrocarbon receptor(AhR) signaling pathway, glycolysis/gluconeogenesis pathway. ConclusionThe therapeutic effect of Baiyaojian on UC is significantly improved after charcoal stir-frying, and the efficacy is more prominent when combined with Angelicae Dahuricae Radix and Mume Fructus Carbonisata, which can provide a basis for the development of Baiyaojian compound preparations.
8.Single-center experience on anti-thrombotic strategies for left ventricular assist device patients
Yahong YU ; Xiaocheng LIU ; Zhigang LIU ; Yu SONG ; Wei WANG ; Kegang JIA ; Yunqiang ZHANG ; Zhengqing WANG
Chinese Journal of Cardiology 2024;52(5):500-504
Objective:Preliminary explore the safety and efficacy of using only vitamin K antagonists without antiplatelet therapy after left ventricular assist devices (LVAD) implantation.Methods:This is a cohort study. Patients who underwent HeartCon LVAD implantation in TEDA International Cardiovascular Hospital from September 2020 to September 2022 were included. Oral warfarin sodium was given on postoperative days 1 to 2, with the target international standardized ratio (INR) of 2.0 to 2.5. Follow-up until September 2022, survival, INR level and occurrence of bleeding and thrombosis were recorded. Survival analysis was performed by the Kaplan-Meier method (censored for heart transplantation).Results:A total of 22 patients, including 16 male patients (72.7%), aged (51.0±13.3) years, were included. The duration of HeartCon LVAD support was (458±166) days and the INR during support was 2.28±0.26. One patient underwent the heart transplant at 307 d after implantation. One patient (4.5%) occured cardiac tamponade, two patients (9.1%) occured hemorrhagic stroke, five patients (22.7%) occured gastrointestinal bleeding, four patients (18.2%) occured gingival hemorrhage, two patients (9.1%) occured epistaxis, one patient (4.5%) occurred ischemic stroke, one patient (4.5%) occured pump thrombosis, and one patient (4.5%) occured aortic valve thrombosis. The survival rates were 100%, 95%, 95%, and 95% at 3 months, 6 months, 1 year, 2 years after implantation respectively.Conclusion:The single antithrombotic strategy using warfarin (target INR 2.0-2.5) without antiplatelet for patients with implantations of HeartCon type LVAD may be safe and effective.
9.Research Advances in Molecular Mechanism of Cardiac Fibrosis Related to Atrial Fibrillation
Yuzhu CHEN ; Yu QIAO ; Yahong LIU ; Guodong NIU
Chinese Circulation Journal 2024;39(12):1229-1233
The pathogenesis of atrial fibrillation is complex and individualized.Cardiac fibrosis plays an important role in the occurrence,recurrence,complications,and treatment of atrial fibrillation by participating in cardiac structural and electrical remodeling.Studies have shown that cardiac fibrosis is associated with extensive neurohumoral regulation and complicated molecular interactions and is regulated by multiple signal pathways.Therefore,cardiac fibrosis is expected to be an effective and promising intervention target for atrial fibrillation.This review article summarizes the current intracellular and extracellular molecular mechanisms of cardiac fibrosis in atrial fibrillation aiming to provide new ideas for the prevention and treatment of atrial fibrillation.
10.Expert consensus on the clinical application of long-acting cabotegravir and rilpivirine
Lijun SUN ; Hongxia WEI ; Haibo DING ; Ping MA ; Hui WANG ; Lijing WANG ; Chunmei WANG ; Min WANG ; Qian WANG ; Hai LONG ; Jinchuan SHI ; Wei LYU ; Biao ZHU ; Jun LIU ; An LIU ; Lianguo RUAN ; Zaicun LI ; Linghua LI ; Huiqin LI ; Shenghua HE ; Meiyin ZOU ; Yuxia SONG ; Renfang ZHANG ; Jian ZHANG ; Xinping YANG ; Yahong CHEN ; Yaokai CHEN ; Hongxin ZHAO ; Qingxia ZHAO ; Zhongsi HONG ; Feng QIAN ; Guangyong XU ; Huihuang HUANG ; Wei CAO ; Jianhua YU ; Juan JIN ; Lin CAI ; Fujie ZHANG
Chinese Journal of Clinical Infectious Diseases 2024;17(6):431-439
The long-acting cabotegravir and rilpivirine injection regimen(CAB+RPV regimen)is the first approved long-acting antiretroviral therapy(ART)for HIV in China,administered once every two months. This regimen provides an innovative alternative to daily oral ART,benefiting virologically suppressed patients. Several large clinical-studies have shown that the CAB+RPV regimen achieves comparable virologic suppression and safety to daily oral regimens,while significantly enhancing patient satisfaction. Based on international and domestic HIV/AIDs guidelines and clinical evidence,this consensus offers expert recommendations on patient selection,clinical management,and key communication strategies for healthcare providers to support the effective use of this regimen,aiming to improve quality of life for people living with HIV and accumulate domestic clinical experience with this advanced treatment approach.

Result Analysis
Print
Save
E-mail